Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−10,934−100.0%Sold outHolders
Q4 202510,934$235.6K<0.1%−4,661−29.9%ReducedHolders
Q3 202515,595$238.0K<0.1%−1,484−8.7%ReducedHolders
Q2 202517,079$151.0K<0.1%−1,685−9.0%ReducedHolders
Q1 202518,764$147.0K<0.1%−18,960−50.3%ReducedHolders
Q4 202437,724$396.0K<0.1%−6,264−14.2%ReducedHolders
Q3 202443,988$577.0K<0.1%−779−1.7%ReducedHolders
Q2 202444,767$629.0K<0.1%+5,460+13.9%AddedHolders
Q1 202439,307$664.0K<0.1%−40,875−51.0%ReducedHolders
Q4 202380,182$1.13M<0.1%+969+1.2%AddedHolders
Q3 202379,213$816.0K<0.1%+2,528+3.3%AddedHolders
Q2 202376,685$1.26M<0.1%+32,150+72.2%AddedHolders
Q1 202344,535$407.0K<0.1%+3,904+9.6%AddedHolders
Q4 202240,631$290.0K<0.1%+7,942+24.3%AddedHolders
Q3 202232,689$163.0K<0.1%+17,000+108.4%AddedHolders
Q2 202215,689$38.0K<0.1%−447−2.8%ReducedHolders
Q1 202216,136$110.0K<0.1%+1,000+6.6%AddedHolders
Q4 202115,136$122.0K<0.1%−1,621−9.7%ReducedHolders
Q3 202116,757$164.0K<0.1%−2,120−11.2%ReducedHolders
Q2 202118,877$127.0K<0.1%−1,700−8.3%ReducedHolders
Q1 202120,577$186.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.